Wednesday, April 10, 2019 | 12:00pm-1:30pm | 2168 Rayburn House Office Building
Dean Kamen, Advanced Regenerative Manufacturing Institute
David Vasko, Rockwell Automation
Jon Rowley, RoosterBio Inc.
Claudia Zylberberg, Akron Biotech
Lunch will be provided. This is a widely-attended public event.
Innovative new advances in biomanufacturing have accelerated groundbreaking new technologies such as engineered tissues, which can be used to create new organs. This increased technical capability can revolutionize modern healthcare by reducing the need of organ donors, as bioengineers will one day be able to grow new organs from a patient’s own cells.
But engineered tissue innovations are currently manufactured on a small scale in laboratory settings at high costs. While federal funding is available through an array of grants, this funding is not sufficient. To facilitate commercial success of these therapies and by reducing cost, new strategies and technical advances must be adopted.
Come join us and hear from our speakers on some of the ways that these emerging technologies will positively impact the cures promised by engineered tissues and the broader range of regenerative medicine therapies.
We hope you can join the House Manufacturing Caucus at this event. Please see the attached flier for additional information.
Tom Reed and Tim Ryan
House Manufacturing Caucus Co-Chairs